Attralus is a Biotech company based in South San Francisco, Country (or null). It has raised $201M in total funding. Latest round: Series B.
Attralus is a Biotech company based in South San Francisco, Country (or null). Attralus has raised $201M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in February 2024. The round record for Attralus runs through 2024; nothing later has been disclosed. Investors on record include venBio Partners, Alpha Wave Ventures, Bristol Myers Squibb, 4BIO Capital, Abingworth, Logos Capital and 5 others. 11 distinct backers are named across the disclosed rounds.
Every Attralus figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in South San Francisco at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026